» Articles » PMID: 36998758

Effects of a Computerized Prescriber Order Entry System on Pharmacist Prescribing

Overview
Date 2023 Mar 31
PMID 36998758
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In Alberta, pharmacists are eligible to obtain additional prescribing authority (APA). At the University of Alberta Hospital, a transition was made from a paper-based prescriber order entry system to a computerized prescriber order entry (CPOE) system.

Objectives: The primary objective was to quantify any change in pharmacist prescribing after CPOE implementation. The secondary objective was to compare the paper-based and CPOE systems in terms of drug schedule, order type, medication class, and the pharmacist's area of clinical practice.

Methods: A retrospective comparative review of pharmacist orders was completed using 2-week periods of data from each of the paper-based order entry system and the CPOE system, spaced 1 year apart (in January 2019 and January 2020).

Results: Pharmacists prescribed a mean of 3.76 (95% confidence interval 1.97-5.96) more orders per day within the CPOE system than in the paper-based system ( < 0.001). Schedule I medications accounted for a higher proportion of pharmacists' prescriptions in the CPOE system than in the paper-based system (77.7% versus 70.5%, < 0.001). In terms of order type, discontinuation orders accounted for a much higher proportion of pharmacists' orders in the CPOE system than in the paper-based order entry system (58.0% versus 19.8%, < 0.001).

Conclusions: This study showed that a CPOE system resulted in more use of APA by pharmacists, with schedule I medications accounting for a higher proportion of pharmacists' prescriptions. With the CPOE system, pharmacists used their prescribing privileges to discontinue a higher proportion of orders than was the case with the paper-based system. Therefore, the CPOE system is a potential facilitator of pharmacist prescribing.

References
1.
Tsuyuki R, Al Hamarneh Y, Jones C, Hemmelgarn B . The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial. J Am Coll Cardiol. 2016; 67(24):2846-54. DOI: 10.1016/j.jacc.2016.03.528. View

2.
Heck T, Gunther M, Bresee L, Mysak T, Mcmillan C, Koshman S . Independent prescribing by hospital pharmacists: Patterns and practices in a Canadian province. Am J Health Syst Pharm. 2015; 72(24):2166-75. DOI: 10.2146/ajhp150080. View

3.
Beahm N, Smyth D, Tsuyuki R . Outcomes of Urinary Tract Infection Management by Pharmacists (ROUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community. Can Pharm J (Ott). 2019; 151(5):305-314. PMC: 6344970. DOI: 10.1177/1715163518781175. View

4.
Saunders S, Dersch-Mills D, Mysak T, Romonko-Slack L, Chernick A, Lazarenko G . CAPABLE: Calgary zone usage of Additional Prescribing Authorization By pharmacists in an inpatient setting: review of the prescribing Landscape and Environment. Res Social Adm Pharm. 2019; 16(3):342-348. DOI: 10.1016/j.sapharm.2019.05.021. View

5.
McAlister F, Majumdar S, Padwal R, Fradette M, Thompson A, Buck B . Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014; 186(8):577-84. PMC: 4016053. DOI: 10.1503/cmaj.140053. View